3DMed Automated Nucleic Acid Extraction System Receives FDA Approval!
In May 2020, 3DMed automated high-throughput nucleic acid extraction system (nucleic acid extractor and supporting kits) was approved by the U.S. Food and Drug Administration. Following the approval of NMPA in China and CE certification in the European Union, 3DMed Nucleic Acid Extraction System has once again been recognized by the global regulatory authorities. This is the first automated high-throughput virus nucleic acid extraction system that has been certified by China NMPA, EU CE and US FDA, and can serve the needs of new coronavirus high-throughput nucleic acid extraction in most countries worldwide.
With the global epidemic of new coronavirus, large-scale nucleic acid detection has become the immediate need, and the high throughput demand for nucleic acid extraction is a major bottleneck, and automated nucleic acid extraction is the key to break this bottleneck. However, most of the current nucleic acid extraction systems are manual and inefficient, which cannot meet the demand for large-scale testing of new coronaviruses; they are also time-consuming and labor-intensive, with poor stability, which affects the accuracy of subsequent nucleic acid virus testing. Based on the above pain points, we have launched a simple, efficient, safe and reliable ANDiS®350 automatic nucleic acid extraction system to help fight the global new coronavirus epidemic.
The ANDiS®350 automated nucleic acid extraction system
Ultra-eﬃcient and rapid
Robust and reliable
The ANDiS®350 Nucleic Acid Extraction System is suitable for different sample types (serum, plasma, swabs, urine, herpes, etc.) and has been proven in tens of thousands of clinical samples. In addition, when used with 3DMed's 2019-nCov nucleic acid detection kits (ANDiS SARS-CoV-2 and Influenza A&B RT-qPCR Detection Kit and ANDiS SARS-CoV-2 RT-qPCR Detection Kit), the detection sensitivity will be higher and the results more accurate.